Italian develops promising vaccine against 'superbacterium'

(ANSA) - Rome, March 9 - A new vaccine against the Staphylococcus aureus 'superbacterium' has been found to work in mice, the journal of the United States National Academy of Sciences (NAS) reported Monday.
    S. aureus is a common cause of skin infections, respiratory disease, and food poisoning, and the emergence of antibiotic-resistant forms has become a worldwide problem in clinical medicine.
    The research at a center run by Swiss pharmaceuticals giant Novartis in the city of Siena is led by world-renowned scientist Rino Rappuoli, a pioneer in the field of vaccines and immunology.
    Rappuoli and his team have developed a vaccine made up of five antigens, or antibody generators, which has proven effective in lab mice.